Tenax Therapeutics Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Tenax Therapeutics Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
TENX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0000034956

Board of directors

Follow this board

Chief executives

Dates unknown

Board connections

3 of this board's directors also sit on 6 other boards.

Network of Tenax Therapeutics Inc.'s board connections Actinium Pharmaceuticals Inc. (Delaware) Actinium Pharmaceutica... Avalo Therapeutics Inc. Avalo Therapeutics Inc... BioAge Labs Inc. BioAge Labs Inc. Dermata Therapeutics Inc. Dermata Therapeutics I... NewAmsterdam Pharma Company N.V. NewAmsterdam Pharma Co... Silence Therapeutics Plc American Depository Share Silence Therapeutics P... Gerald T. Proehl Gerald T. Proehl June Sherie Almenoff June Sherie Almenoff Michael H. Davidson Michael H. Davidson Tenax Therapeutics Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Aug 8, 2024 Gerald T. Proehl Director Open-market purchase +1,666 — —
Aug 8, 2024 Michael H. Davidson Director Open-market purchase +2,500 — —

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.